Skip to content

Inogen INGN Contract Liabilities

Contract Liabilities at other companies

ResMed logo
ResMedRMD
$163.15M+8.0%
Pulmonx Corporation logo
Pulmonx CorporationLUNG
$100K0.0%

Segments

By product

See full
Lifetime Warranties$6.82M-31.3%

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's contract liabilities?
Inogen (INGN) reported contract liabilities of $3.17M in Q1 2026.
How has Inogen's contract liabilities changed year-over-year?
Inogen's contract liabilities decreased by 37.9% year-over-year, from $5.11M to $3.17M.
What is the long-term trend for Inogen's contract liabilities?
Over 5 years (2020 to 2025), Inogen's contract liabilities has grown at a -21.2% compound annual growth rate (CAGR), from $11.82M to $3.6M.
What does contract liabilities mean?
Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.